Evolution of HIV-1 in an HLA-B*57-positive patient during virologic escape

Journal of Infectious Diseases

Volumn 196, Issue 1, 2007, Pages 50-55

  Bailey, Justin R ^a   Zhang, Haili ^a   Wegweiser, Barbara W ^a   Yang, Hung Chih ^a   Herrera, Laura ^a   Ahonkhai, Aima ^a   Williams, Thomas M ^c,d   Siliciano, Robert F ^a,b   Blankson, Joel N ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^c UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^d TRICORE REFERENCE LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; EFAVIRENZ; EPITOPE; HLA B57 ANTIGEN; LAMIVUDINE; LOPINAVIR; RITONAVIR; VIRUS PROTEIN; VPU PROTEIN; ZIDOVUDINE;

ADULT; ARTICLE; CASE REPORT; CD8+ T LYMPHOCYTE; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MUTATION; NONHUMAN; PRIORITY JOURNAL; SEROCONVERSION; VIRUS ISOLATION; VIRUS LOAD; VIRUS REPLICATION;

ADULT; AMINO ACID SUBSTITUTION; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; DNA MUTATIONAL ANALYSIS; DRUG RESISTANCE, VIRAL; EPITOPES, T-LYMPHOCYTE; EVOLUTION, MOLECULAR; GENE PRODUCTS, GAG; GENE PRODUCTS, VPU; GENOME, VIRAL; HIV INFECTIONS; HIV-1; HLA-B ANTIGENS; HUMANS; MALE; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; RNA, VIRAL;

EID: 34250808612     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/518515     Document Type: Article

References (15)

1. Migueles SA, Sabbaghian MS, Shupert WL, et al. HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc Natl Acad Sci USA 2000; 97: 2709-14.
2. Altfeld M, Addo MM, Rosenberg ES, et al. Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection. AIDS 2003; 17:2581-91.
3. Migueles SA, Laborico AC, Imamichi H, et al. The differential ability of HLA B*5701+ long-term nonprogressors and progressors to restrict human immunodeficiency virus replication is not caused by loss of recognition of autologous viral gag sequences. J Virol 2003; 77:6889-98.
4. Blankson IN, Bailey IR, Thayil S, et al. Isolation and characterization of replication-competent HIV-1 from a subset of elite suppressors. J Virol 2007; 81:2508-18.
5. Zhang H, Zhou Y, Alcock C, et al. Novel single-cell-level phenotypic assay for residual drug susceptibility and reduced replication capacity of drug-resistant human immunodeficiency virus type 1. J Virol 2004; 78:1718-29.
6. Bailey IR, Lassen KG, Yang HC, et al. Neutralizing antibodies do not mediate suppression of human immunodeficiency virus type 1 in elite suppressors or selection of plasma virus variants in patients on highly active antiretroviral therapy. J Virol 2006; 80:4758-70.
7. Bailey IR, Williams TM, Siliciano RF, Blankson IN. Maintenance of viral suppression in HIV-1-infected HLA-B*57+ elite suppressors despite CTL escape mutations. J Exp Med 2006; 203:1357-69.
8. Gandhi RT, Wurcel A, Rosenberg ES, et al. Progressive reversion of human immunodeficiency virus type 1 resistance mutations in vivo after transmission of a multiply drug-resistant virus. Clin Infect Dis 2003; 37:1693-8.
9. Kosalaraksa P, Kavlick MF, Maroun V, Le R, Mitsuya H. Comparative fitness of multi-dideoxynucleoside-resistant human immunodeficiency virus type 1 (HIV-1) in an in vitro competitive HIV-1 replication assay. I Virol 1999; 73:5356-63.
10. Campbell TB, Schneider K, Wrin T, Petropoulos CJ, Connick E. Relationship between in vitro human immunodeficiency virus type 1 replication rate and virus load in plasma. J Virol 2003; 77:12105-12.
11. Draenert R, Le Gall S, Pfafferott KJ, et al. Immune selection for altered antigen processing leads to cytotoxic T lymphocyte escape in chronic HIV-1 infection. J Exp Med 2004; 199:905-15.
12. Feeney ME, Tang Y, Roosevelt KA, et al. Immune escape precedes breakthrough human immunodeficiency virus type 1 viremia and broadening of the cytotoxic T-lymphocyte response in an HLA-B27-positive long-term-nonprogressing child. J Virol 2004; 78:8927-30.
13. Goulder PJ, Phillips RE, Colbert RA, et al. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat Med 1997; 3:212-7.
14. Barouch DH, Kunstman J, Kuroda MJ, et al. Eventual AIDS vaccine failure in a rhesus monkey by viral escape from cytotoxic T lymphocytes. Nature 2002; 415:335-9.
15. Binette J, Cohen EA. Recent advances in the understanding of HIV-1 Vpu accessory protein functions. Curr Drug Targets Immune Endocr Metabol Disord 2004; 4:297-307.